India's pharma sector revenue projected to grow 11–13% in FY27

The Economic Times reports Crisil's forecast of 11–13% revenue growth for India's pharmaceutical sector in FY27, driven by strong exports and domestic demand. The domestic market is expected to expand 9–11% as prescription demand rises. Raw-material and freight inflation may compress operating margins by 150–200 basis points, equivalent to 1.5–2 percentage points. The report says strong cash generation and healthy balance sheets should help maintain credit profiles despite that pressure.